Embecta Corp., a global medical supplies company with a 100-year legacy in insulin delivery, reported its second quarter fiscal 2026 financial results on May 5, 2026. The company also declared a quarterly cash dividend of $0.01 per share. Embecta continues to focus on expanding its medical supplies business and improving lives through innovative solutions. Investors can access the detailed earnings release and listen to the company's conference call for more insights.
Solaris Energy Infrastructure (SEI) maintains a Buy rating with a new price target of $97, driven by strong growth from its Power Solutions segment and a 2.2GW contracted capacity with major tech clients. Its upcoming inclusion in the S&P SmallCap 60...
XRP Ledger's AI agents have completed over 1 million transactions but with low financial volume, indicating the AI economy is still in early stages. Bitcoin mining veteran Chandler Guo predicts Bitcoin will hit $120,000 within a year and $500,000 in ...
Argan, Inc. reported a strong first quarter for fiscal year 2027 with a 50% increase in revenue, reaching a record $290.9 million. This growth was fueled by multiple project completions and a robust $2.8 billion backlog, supported by rising energy de...
The Global X Russell 2000 Covered Call ETF (RYLD) provides a high monthly yield of 11.9% and achieved a 20.5% total return over the past year. However, its strategy involving at-the-money options causes structural net asset value (NAV) erosion and ca...
A Cambridge study found Ethereum's annual energy consumption at 7.87 gigawatt-hours, making it the second-least energy-intensive proof-of-stake (PoS) blockchain when adjusted for market value. This marks a significant improvement from its previous pr...
